MedTrace Logo

Local Infiltration Analgesia After Abdominal Hysterectomy

NCT01782781 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2015-01-21

No results posted yet for this study

Summary

The aim of the study is to evaluate traditional analgesic therapy after abdominal hysterectomy with single infiltration of local anesthetics in the surgical area at the end of surgery.

Conditions

Interventions

DRUG

ropivacaine, ketorelac and epinephrine

Active group

DRUG

Placebo

Placebo group

Sponsors & Collaborators

  • Göteborg University

    lead OTHER

Principal Investigators

  • Sven-Egron Thorn, MD, PhD · Dept. of Anesthesia and Intensive Care, Sahlgrenska University Hospital, Goteborg, Sweden

  • Anil Gupta, MD, PhD · Dept. of Anesthesia and Intensive Care, Orebro University Hospital, Orebro, Sweden

  • Ove Carlsson, MD · Dept. of Anesthesia and Intensive Care, Sahlgrenska University Hospital, Goteborg, Sweden

  • Karin Olausson, MD · Dept. of Anesthesia and Intensive Care, Sahlgrenska University Hospital, Goteborg, Sweden

  • Olof Eckre, MD, PhD · Dept. of Anesthesia and Intensive Care, Sahlgrenska University Hospital, Goteborg, Sweden

  • Sven-Erik Ricksten, MD,PhD · Dept. of Anesthesia and Intensive Care, Sahlgrenska University Hospital, Goteborg, Sweden

  • Fatma Backman, MD · Dept. of Gynecological Surgery, Orebro University Hospital, Orebro, Sweden

  • Elisabeth Stadberg, MD · Dept. of Gynecological Surgery, Sahlgrenska University Hospital, Goteborg, Sweden

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01782781 on ClinicalTrials.gov